Prosight Management, LP Care Dx, Inc. Transaction History
Prosight Management, LP
- $337 Million
- Q4 2024
A detailed history of Prosight Management, LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 80,000 shares of CDNA stock, worth $1.96 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
80,000Holding current value
$1.96 Million% of portfolio
0.51%Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
223Shares Held
54.5MCall Options Held
59.3KPut Options Held
28K-
Black Rock Inc. New York, NY5.29MShares$130 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$119 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$65.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$59 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$54.1 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.31B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...